Items Tagged ‘Gastric Cancer’

December 21, 2017

Diagnosed with Gastric Cancer: 10 Tips on How to Get The Most From Your Doctor

By

1) Choose Your Doctor Carefully Surgeons, medical oncologists and radiation oncologists are the primary doctors involved with gastric cancer and often work in collaboration. Pick your primary oncologist carefully, rely on people you trust including nurses and other health care professionals who make help with recommendations.  Make sure your doctor is someone you feel comfortable […]

View full entry

Tags: Gastric Cancer, News


October 3, 2017

New Standard of Care for Treatment of Resectable Gastric Cancer

By

The superiority of docetaxel based triplet therapy over standard care in patients with resectable esophago-gastric cancer has been confirmed in late-breaking results from the FLOT4 trial presented at the ESMO 2017 Congress in Madrid.1 Survival in resectable esophago-gastric cancer is poor. Five-year overall survival is around 25% with surgery, and is increased to 36% by […]

View full entry

Tags: Esophageal Cancer, esophago-gastric cancer, Gastric Cancer, News


September 25, 2017

The US Food and Drug Administration has Expanded the Approval of the Precision Cancer Medicine Keytruda for Treatment of Gastric Cancer

By

Keytruda (Pembrolizumab) is now indicated for patients with recurrent locally advanced or metastatic gastric or gastro-esophogeal junction adenocarcinoma. Patients eligible for keytruda therapy under this new indication must have PD-L1-expressing tumors, and must demonstrate disease progression after two or more prior lines of therapy – including fluoropyrimidine- and platinum-containing chemotherapy and, in some cases, HER2/neu-targeted […]

View full entry

Tags: checkpoint inhibitor, Esophageal Cancer, Gastric Cancer, gastro-esophogeal junction cancer, keytruda, metastatic gastric, News, pembrolizumab, Precision Cancer Medicine


September 18, 2017

Keytruda Immunotherapy Appears Promising in Advanced Gastric Cancer

By

Keytruda (pembrolizumab) appears promising in patients with pretreated metastatic gastric cancer, according to late-breaking results from the KEYNOTE-059 trial presented at the European Society for Medical Oncology (ESMO) 2017 Congress in Madrid.1 Stomach cancer (gastric cancer), is the third leading cause of cancer-related deaths worldwide. Overall, the 5-year survival rate for patients with gastric cancer […]

View full entry

Tags: Gastric Cancer, immunotherapy, KEYNOTE-059 programmed death-ligand 1, keytruda, metastatic gastric cancer, News, PD-L1, pembrolizumab, Precision Cancer Medicine, stomach cancer


March 31, 2009

Gleevec® Reduces Risk of Recurrence After Surgery for Localized Gastrointestinal Stromal Tumors

By

Among patients with localized gastrointestinal stromal tumors, adjuvant (post-surgery) treatment with the targeted therapy Gleevec® (imatinib mesylate) reduces the risk of cancer recurrence. These results were published in The Lancet. Gastrointestinal stromal tumors (GIST) are a relatively rare but aggressive type of soft-tissue sarcoma. These cancers are most commonly found in the stomach or small […]

View full entry

Tags: Gastric Cancer


February 5, 2009

Gastric Cancer Patients: Understanding Peripheral Neuropathy

By

If you’ve received chemotherapy as part of your gastric cancer treatment, one of the side effects you may experience is numbness and tingling in you extremities, also known as peripheral neuropathy. The following guidelines explain how to recognize and manage this condition. What Is Peripheral Neuropathy? Numbness and tingling of your extremities (hands and feet) […]

View full entry

Tags: Gastric Cancer